These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 29509240)
61. Dihydroartemisinin potentiates the anticancer effect of cisplatin via mTOR inhibition in cisplatin-resistant ovarian cancer cells: involvement of apoptosis and autophagy. Feng X; Li L; Jiang H; Jiang K; Jin Y; Zheng J Biochem Biophys Res Commun; 2014 Feb; 444(3):376-81. PubMed ID: 24462866 [TBL] [Abstract][Full Text] [Related]
62. PDCD1 strengthens the sensitivity of ovarian cancer to cisplatin chemotherapy by promoting apoptosis. Li Q; Gao JF; Qi BL J BUON; 2017; 22(3):746-756. PubMed ID: 28730785 [TBL] [Abstract][Full Text] [Related]
63. Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non--Small-Cell Lung Cancer Cells. Liu JT; Li WC; Gao S; Wang F; Li XQ; Yu HQ; Fan LL; Wei W; Wang H; Sun GP Clin Lung Cancer; 2015 Sep; 16(5):e55-66. PubMed ID: 25979647 [TBL] [Abstract][Full Text] [Related]
64. Long non-coding RNA ENST00000457645 reverses cisplatin resistance in CP70 ovarian cancer cells. Yan H; Xia JY; Feng FZ Genet Mol Res; 2017 Jan; 16(1):. PubMed ID: 28128423 [TBL] [Abstract][Full Text] [Related]
65. Long noncoding RNA growth arrest-specific 5 facilitates glioma cell sensitivity to cisplatin by suppressing excessive autophagy in an mTOR-dependent manner. Huo JF; Chen XB J Cell Biochem; 2019 Apr; 120(4):6127-6136. PubMed ID: 30317677 [TBL] [Abstract][Full Text] [Related]
66. Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells. Lin JF; Lin YC; Tsai TF; Chen HE; Chou KY; Hwang TI Drug Des Devel Ther; 2017; 11():1517-1533. PubMed ID: 28553083 [TBL] [Abstract][Full Text] [Related]
67. Luteolin sensitizes the antitumor effect of cisplatin in drug-resistant ovarian cancer via induction of apoptosis and inhibition of cell migration and invasion. Wang H; Luo Y; Qiao T; Wu Z; Huang Z J Ovarian Res; 2018 Nov; 11(1):93. PubMed ID: 30454003 [TBL] [Abstract][Full Text] [Related]
68. Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines. Gibb RK; Taylor DD; Wan T; O'Connor DM; Doering DL; Gerçel-Taylor C Gynecol Oncol; 1997 Apr; 65(1):13-22. PubMed ID: 9103385 [TBL] [Abstract][Full Text] [Related]
69. LncRNA RP11-551L14.4 suppresses breast cancer development by inhibiting the expression of miR-4472. Wang B; Chen H; Yang R; Xing L; Chen C; Chen J PeerJ; 2022; 10():e14482. PubMed ID: 36523479 [TBL] [Abstract][Full Text] [Related]
70. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner. Yan X; Fraser M; Qiu Q; Tsang BK Gynecol Oncol; 2006 Aug; 102(2):348-55. PubMed ID: 16545436 [TBL] [Abstract][Full Text] [Related]
71. BNIP3 contributes to cisplatin-induced apoptosis in ovarian cancer cells. Jia J; Yang X; Zhao Q; Ying F; Cai E; Sun S; He X FEBS Open Bio; 2020 Aug; 10(8):1463-1473. PubMed ID: 32412667 [TBL] [Abstract][Full Text] [Related]
72. [Reversal of drug resistance in human ovarian cancer cells by wild-type PTEN gene and its mechanisms]. Wu HJ; Wu HT; Weng DH; Xing H; Lu YP; Ma D Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):612-6. PubMed ID: 17983517 [TBL] [Abstract][Full Text] [Related]
73. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma. Ma JJ; Chen BL; Xin XY Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744 [TBL] [Abstract][Full Text] [Related]
74. Depletion of the lncRNA RP11-567G11.1 inhibits pancreatic cancer progression. Huang R; Nie W; Yao K; Chou J Biomed Pharmacother; 2019 Apr; 112():108685. PubMed ID: 30802827 [TBL] [Abstract][Full Text] [Related]
75. The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma. Chen S; Wu DD; Sang XB; Wang LL; Zong ZH; Sun KX; Liu BL; Zhao Y Cell Death Dis; 2017 Oct; 8(10):e3118. PubMed ID: 29022892 [TBL] [Abstract][Full Text] [Related]
76. Chloroquine enhances the efficacy of cisplatin by suppressing autophagy in human adrenocortical carcinoma treatment. Qin L; Xu T; Xia L; Wang X; Zhang X; Zhang X; Zhu Z; Zhong S; Wang C; Shen Z Drug Des Devel Ther; 2016; 10():1035-45. PubMed ID: 27022243 [TBL] [Abstract][Full Text] [Related]
77. Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro. Tang YJ; Sun ZL; Wu WG; Xing J; He YF; Xin DM; Han P Genet Mol Res; 2015 Mar; 14(1):2450-60. PubMed ID: 25867391 [TBL] [Abstract][Full Text] [Related]
78. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs. Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496 [TBL] [Abstract][Full Text] [Related]
79. [Lumican enhanced the therapeutic effect of cisplatin-resistant ovarian cancer by inhibiting the differentiation of Th1 cells]. Chen P; Wu R; Gao X; Zhao Y; Yuan Y Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Aug; 40(8):687-695. PubMed ID: 39215666 [TBL] [Abstract][Full Text] [Related]
80. MicroRNA-143 Sensitizes Cervical Cancer Cells to Cisplatin: a Promising Anticancer Combination Therapy. Esfandyari YB; Doustvandi MA; Amini M; Baradaran B; Zaer SJ; Mozammel N; Mohammadzadeh M; Mokhtarzadeh A Reprod Sci; 2021 Jul; 28(7):2036-2049. PubMed ID: 33569751 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]